Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Merkel Cell 1

Interventions

avelumab 2Capecitabine 2veliparib 1domatinostat 1antineoplaston AS 2-1 1antineoplaston A10 1Temozolomide 1Radiosurgery 1Omacor 1Leucovorin 1Ipilimumab 1Fluorouracil 1Cyclophosphamide 1Complementary Therapies 1Cisplatin 1Biological Therapy 1Bevacizumab 1ALT-803 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Merkel Cell × domatinostat × Clear all
NCT04874831 2021-11-18

Domatinostat in Combination With Avelumab in Patients With Treatment-naïve Metastatic Merkel Cell Carcinoma (MERKLIN 1)

4SC AG

Phase 2 Withdrawn
Dermatologic

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡